Review Article| Volume 102, ISSUE 3, P499-516, June 2022

Epidemiology of Coronary Artery Disease


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Surgical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kochanek K.D.X.J.
        • Arias E.
        Mortality in the United States, 2019. NCHS data brief, no 395.
        National Center for Health Statistics, Hyattsville, MD2020
        • Virani S.S.
        • Alonso A.
        • Aparicio H.J.
        • et al.
        Heart disease and stroke statistics-2021 update: a report from the american heart association.
        Circulation. 2021; 143: e254-e743
        • Odden M.C.
        • Coxson P.G.
        • Moran A.
        • et al.
        The impact of the aging population on coronary heart disease in the United States.
        Am J Med. 2011; 124: 827-833.e825
      1. (Office of Disease Prevention and Health Promotion)Healthy People 2020. U.S. Department of Health and Human Services, Washington, DC2021 (Available at:) (Accessed 01 August 2021)
        • Mahmood S.S.
        • Levy D.
        • Vasan R.S.
        • et al.
        The framingham heart study and the epidemiology of cardiovascular disease: a historical perspective.
        Lancet. 2014; 383: 999-1008
        • Kannel W.B.
        • Dawber T.R.
        • Kagan A.
        • et al.
        Factors of risk in the development of coronary heart disease--six year follow-up experience. The framingham study.
        Ann Intern Med. 1961; 55: 33-50
        • D'Agostino R.B.
        • Vasan R.S.
        • Pencina M.J.
        • et al.
        General cardiovascular risk profile for use in primary care: the Framingham Heart Study.
        Circulation. 2008; 117: 743-753
        • Lloyd-Jones D.M.
        • Leip E.P.
        • Larson M.G.
        • et al.
        Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age.
        Circulation. 2006; 113: 791-798
        • Kotchen T.A.
        Historical trends and milestones in hypertension research: a model of the process of translational research.
        Hypertension. 2011; 58: 522-538
        • Goff Jr., D.C.
        • Lloyd-Jones D.M.
        • Bennett G.
        • et al.
        2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/american heart association task force on practice guidelines.
        J Am Coll Cardiol. 2014; 63: 2935-2959
        • Lewington S.
        • Clarke R.
        • Qizilbash N.
        • et al.
        Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.
        Lancet. 2002; 360: 1903-1913
        • Rosendorff C.
        • Black H.R.
        • Cannon C.P.
        • et al.
        Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the american heart association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention.
        Circulation. 2007; 115: 2761-2788
        • Arnett D.K.
        • Blumenthal R.S.
        • Albert M.A.
        • et al.
        2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the american college of cardiology/american heart association task force on clinical practice guidelines.
        Circulation. 2019; 140: e596-e646
        • Samanic C.M.
        • Barbour K.E.
        • Liu Y.
        • et al.
        Prevalence of self-reported hypertension and antihypertensive medication use among adults - United States, 2017.
        MMWR Morb Mortal Wkly Rep. 2020; 69: 393-398
        • Hajar R.
        Statins: past and present.
        Heart Views. 2011; 12: 121-127
        • Endo A.
        A historical perspective on the discovery of statins.
        Proc Jpn Acad Ser B Phys Biol Sci. 2010; 86: 484-493
      2. The lipid research clinics coronary primary prevention trial results. I. reduction in incidence of coronary heart disease.
        JAMA. 1984; 251: 351-364
        • Blais J.E.
        • Wei Y.
        • Yap K.K.W.
        • et al.
        Trends in lipid-modifying agent use in 83 countries.
        Atherosclerosis. 2021; 328: 44-51
        • Salami J.A.
        • Warraich H.
        • Valero-Elizondo J.
        • et al.
        National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the medical expenditure panel survey.
        JAMA Cardiol. 2017; 2: 56-65
      3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study.
        Lancet. 1994; 344: 1383-1389
        • Grundy S.M.
        • Stone N.J.
        • Bailey A.L.
        • et al.
        2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        J Am Coll Cardiol. Jun 25 2019; 73: e285-e350
        • Yao X.
        • Shah N.D.
        • Gersh B.J.
        • et al.
        Assessment of trends in statin therapy for secondary prevention of atherosclerotic cardiovascular disease in US adults from 2007 to 2016.
        JAMA Netw Open. 2020; 3: e2025505
        • Centers for Disease Control and Prevention
        National diabetes statistics report, 2020.
        (Centers for Disease Control and Prevention) U.S. Dept of Health and Human Services, Atlanta, GA2020
        • Leon B.M.
        • Maddox T.M.
        Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research.
        World J Diabetes. 2015; 6: 1246-1258
        • Lee C.D.
        • Folsom A.R.
        • Pankow J.S.
        • et al.
        Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction.
        Circulation. 2004; 109: 855-860
        • Kappetein A.P.
        • Head S.J.
        • Morice M.C.
        • et al.
        Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
        Eur J Cardiothorac Surg. 2013; 43: 1006-1013
        • Nicholls S.J.
        • Tuzcu E.M.
        • Kalidindi S.
        • et al.
        Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials.
        J Am Coll Cardiol. 2008; 52: 255-262
        • Lester W.M.
        • Roberts W.C.
        Diabetes mellitus for 25 years or more. Analysis of cardiovascular findings in seven patients studied at necropsy.
        Am J Med. 1986; 81: 275-279
        • Iwakawa N.
        • Tanaka A.
        • Ishii H.
        • et al.
        Impact of diabetes mellitus on the aortic wall changes as atherosclerosis progresses: aortic dilatation and calcification.
        J Atheroscler Thromb. 2020; 27: 509-515
        • Haffner S.M.
        • Lehto S.
        • Rönnemaa T.
        • et al.
        Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
        N Engl J Med. 1998; 339: 229-234
        • U.S. Department of Health and Human Services
        The health consequences of smoking: 50 Years of progress. A report of the surgeon general.
        U.S. Department of Health and Human Services, Centers for Disease Control and Prevention,, Atlanta, GA2014 (National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Printed with corrections)
        • U.S. Department of Health and Human Services.
        Smoking Cessation. A Report of the Surgeon General.
        U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA2020
        • Hubert H.B.
        • Feinleib M.
        • McNamara P.M.
        • et al.
        Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.
        Circulation. 1983; 67: 968-977
        • U.S. Department of Health and Human Services
        How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general.
        U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA2010
        • Law M.R.
        • Morris J.K.
        • Wald N.J.
        Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence.
        BMJ. 1997; 315: 973-980
        • Thun M.J.
        • Carter B.D.
        • Feskanich D.
        • et al.
        50-year trends in smoking-related mortality in the United States.
        N Engl J Med. 2013; 368: 351-364
        • Teo K.K.
        • Ounpuu S.
        • Hawken S.
        • et al.
        Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study.
        Lancet. 2006; 368: 647-658
        • U.S. Department of Health and Human Services
        E-Cigarette use among youth and young adults. A Report of the Surgeon General.
        U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA2016
        • Wang T.W.
        • Gentzke A.S.
        • Creamer M.R.
        • et al.
        Tobacco product use and associated factors among middle and high school students - United States, 2019.
        MMWR Surveill Summ. 2019; 68: 1-22
        • Calle E.E.
        • Thun M.J.
        • Petrelli J.M.
        • et al.
        Body-mass index and mortality in a prospective cohort of U.S. adults.
        N Engl J Med. 1999; 341: 1097-1105
        • Li T.Y.
        • Rana J.S.
        • Manson J.E.
        • et al.
        Obesity as compared with physical activity in predicting risk of coronary heart disease in women.
        Circulation. 2006; 113: 499-506
        • Van Gaal L.F.
        • Mertens I.L.
        • De Block C.E.
        Mechanisms linking obesity with cardiovascular disease.
        Nature. 2006; 444: 875-880
        • Zamboni M.
        • Armellini F.
        • Sheiban I.
        • et al.
        Relation of body fat distribution in men and degree of coronary narrowings in coronary artery disease.
        Am J Cardiol. 1992; 70: 1135-1138
        • Matsuzawa Y.
        The metabolic syndrome and adipocytokines.
        FEBS Lett. 2006; 580: 2917-2921
        • Piercy K.L.
        • Troiano R.P.
        • Ballard R.M.
        • et al.
        The Physical Activity Guidelines for Americans.
        JAMA. 2018; 320: 2020-2028
        • Winzer E.B.
        • Woitek F.
        • Linke A.
        Physical Activity in the Prevention and Treatment of Coronary Artery Disease.
        J Am Heart Assoc. 2018; 7
        • Merlo C.L.
        • Jones S.E.
        • Michael S.L.
        • et al.
        Dietary and Physical activity behaviors among high school students - youth risk behavior survey, United States, 2019.
        MMWR Suppl. 2020; 69: 64-76
        • Sones Jr., F.M.
        • Shirey E.K.
        Cine coronary arteriography.
        Mod Concepts Cardiovasc Dis. 1962; 31: 735-738
        • Stoney W.S.
        Evolution of cardiopulmonary bypass.
        Circulation. 2009; 119: 2844-2853
        • Kolessov V.I.
        Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris.
        J Thorac Cardiovasc Surg. 1967; 54: 535-544
        • Mueller R.L.
        • Rosengart T.K.
        • Isom O.W.
        The history of surgery for ischemic heart disease.
        Ann Thorac Surg. 1997; 63: 869-878
        • Favaloro R.G.
        Landmarks in the development of coronary artery bypass surgery.
        Circulation. 1998; 98: 466-478
        • Iqbal J.
        • Gunn J.
        • Serruys P.W.
        Coronary stents: historical development, current status and future directions.
        Br Med Bull. 2013; 106: 193-211
        • Booth J.
        • Clayton T.
        • Pepper J.
        • et al.
        Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS).
        Circulation. 2008; 118: 381-388
        • Daemen J.
        • Boersma E.
        • Flather M.
        • et al.
        Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
        Circulation. 2008; 118: 1146-1154
        • Serruys P.W.
        • Morice M.C.
        • Kappetein A.P.
        • et al.
        Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
        N Engl J Med. 2009; 360: 961-972
        • Farkouh M.E.
        • Domanski M.
        • Sleeper L.A.
        • et al.
        Strategies for multivessel revascularization in patients with diabetes.
        N Engl J Med. 2012; 367: 2375-2384
        • Park S.J.
        • Ahn J.M.
        • Kim Y.H.
        • et al.
        Trial of everolimus-eluting stents or bypass surgery for coronary disease.
        N Engl J Med. 2015; 372: 1204-1212
        • Holm N.R.
        • Mäkikallio T.
        • Lindsay M.M.
        • et al.
        Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
        Lancet. 2020; 395: 191-199
        • Stone G.W.
        • Sabik J.F.
        • Serruys P.W.
        • et al.
        Everolimus-eluting stents or bypass surgery for left main coronary artery disease.
        N Engl J Med. 2016; 375: 2223-2235
        • Neumann F.J.
        • Sousa-Uva M.
        • Ahlsson A.
        • et al.
        2018 ESC/EACTS guidelines on myocardial revascularization.
        Eur Heart J. 2019; 40: 87-165
        • Hillis L.D.
        • Smith P.K.
        • Anderson J.L.
        • et al.
        2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the american college of cardiology foundation/american heart association task force on practice guidelines.
        Circulation. 2011; 124: e652-e735
        • Alkhouli M.
        • Alqahtani F.
        • Kalra A.
        • et al.
        Trends in characteristics and outcomes of patients undergoing coronary revascularization in the United States, 2003-2016.
        JAMA Netw Open. 2020; 3: e1921326
        • D'Agostino R.S.
        • Jacobs J.P.
        • Badhwar V.
        • et al.
        The society of thoracic surgeons adult cardiac surgery database: 2018 update on outcomes and quality.
        Ann Thorac Surg. 2018; 105: 15-23
        • Ferguson Jr., T.B.
        • Hammill B.G.
        • Peterson E.D.
        • et al.
        A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS national database committee and the duke clinical research institute. society of thoracic surgeons.
        Ann Thorac Surg. 2002; 73 ([discussion 489-490]): 480-489
        • Cornwell L.D.
        • Omer S.
        • Rosengart T.
        • et al.
        Changes over time in risk profiles of patients who undergo coronary artery bypass graft surgery: the veterans affairs surgical quality improvement program (VASQIP).
        JAMA Surg. 2015; 150: 308-315
        • Bommer C.
        • Sagalova V.
        • Heesemann E.
        • et al.
        Global economic burden of diabetes in adults: projections from 2015 to 2030.
        Diabetes Care. 2018; 41: 963-970
        • Shahian D.M.
        • O'Brien S.M.
        • Filardo G.
        • et al.
        The society of thoracic surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery.
        Ann Thorac Surg. 2009; 88: S2-S22
        • Alserius T.
        • Hammar N.
        • Nordqvist T.
        • et al.
        Improved survival after coronary artery bypass grafting has not influenced the mortality disadvantage in patients with diabetes mellitus.
        J Thorac Cardiovasc Surg. 2009; 138: 1115-1122
        • Brown J.C.
        • Gerhardt T.E.
        • Kwon E.
        Risk factors for coronary artery disease. StatPearls..
        StatPearls Publishing, Treasure Island (FL)2021
        • Anand S.S.
        • Xie C.C.
        • Mehta S.
        • et al.
        Differences in the management and prognosis of women and men who suffer from acute coronary syndromes.
        J Am Coll Cardiol. 2005; 46: 1845-1851